Neogenomics INC (NEO) — 8-K Filings

8-K Filings (14)

• 8-K Filing — Dec 30, 2025
• NeoGenomics Announces Board Changes — Aug 8, 2025 Risk: low
  On August 5, 2025, NeoGenomics, Inc. announced the departure of Director Dr. Jonathan R. Rothberg and the election of new Director Dr. David J. Halbert. The com
• NeoGenomics Inc. Files 8-K on Financials — Jul 29, 2025 Risk: low
  On July 29, 2025, NeoGenomics Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as fi
• NeoGenomics Board Shake-up: Two Directors Depart, Two New Ones Elected — Jun 24, 2025 Risk: medium
  On June 19, 2025, NeoGenomics, Inc. filed an 8-K report detailing the departure of two directors, Mark Goldsmith and Robert Lamy, effective June 17, 2025. The c
• NeoGenomics Files 8-K: Officer Departures, Director Elections — May 27, 2025 Risk: medium
  On May 22, 2025, NeoGenomics, Inc. filed an 8-K report detailing the departure of certain officers and the election of new directors. The filing also covers the
• NeoGenomics Files 8-K for Bylaw, Charter Amendments — Apr 8, 2025 Risk: low
  On April 4, 2025, NeoGenomics, Inc. filed an 8-K report detailing amendments to its Articles of Incorporation and Bylaws. The filing also includes financial sta
• NeoGenomics Reports Director Changes and Officer Compensation Adjustments — Mar 18, 2025 Risk: medium
  On March 18, 2025, NeoGenomics Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the electio
• NeoGenomics Announces Leadership Changes and Compensatory Arrangements — Jan 15, 2025 Risk: medium
  On January 14, 2025, NeoGenomics, Inc. announced the departure of Director Dr. Jonathan R. Rothberg and the appointment of Dr. David M. Goldenberg as Chief Medi
• NeoGenomics Announces Board and Executive Changes — Jan 10, 2025 Risk: medium
  On January 3, 2025, NeoGenomics, Inc. announced changes in its board of directors and executive compensation. The company filed an 8-K report detailing the depa
• NeoGenomics Files 8-K: Operations, Board & Officer Changes — Nov 5, 2024 Risk: medium
  On November 1, 2024, NeoGenomics, Inc. filed an 8-K report detailing significant corporate events. The filing includes information regarding the company's resul
• NeoGenomics Inc. Files 8-K on Financials — Jul 29, 2024 Risk: low
  On July 29, 2024, NeoGenomics Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as fi
• NeoGenomics Holds Annual Stockholder Meeting — May 24, 2024 Risk: low
  On May 23, 2024, NeoGenomics, Inc. filed an 8-K report to announce the results of its annual meeting of stockholders. The company's stockholders voted on severa
• NeoGenomics Appoints New CEO, Dr. Mark Mallon — Apr 18, 2024 Risk: medium
  On April 15, 2024, NeoGenomics Inc. announced the appointment of Dr. Mark Mallon as Chief Executive Officer and a member of the Board of Directors, effective im
• NeoGenomics Grants Performance Share Units to Officers — Feb 23, 2024 Risk: low
  NeoGenomics, Inc. filed an 8-K on February 23, 2024, reporting on compensatory arrangements for certain officers, specifically the grant of Performance Share Un

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX